Tony Arulanandam
![Tony Arulanandam Tony Arulanandam](https://cell-therapy-autoimmune-disease.com/wp-content/uploads/sites/878/2024/07/speaker-photos-47406-29-150x150.png)
Company: Synaptimmune Therapeutics
Job title: CEO and Founder
Seminars:
Next Generation of Dual Antigen IDR-CAR-T cells for Autoimmune Diseases 2:30 pm
• Discussing increased potency, sensitivity and complete immune reset of dual antigen targeting IDR-CAR-T cells • Proof of concept data for SLE and other autoantibodymediated autoimmune indications targeting B and T-cells • Development of best-in-class next generation of immune cell depleting CAR-T cells and tissue or organ system modulating CAR-Tregs NEW DATARead more
day: Day One Track A, PM